These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9323798)

  • 1. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.
    Ganser A; Bergmann M; Völkers B; Grützmacher P; Scigalla P; Hoelzer D
    Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of recombinant human erythropoietin on bone marrow progenitor cells.
    Jaar B; Baillou C; Viron B; Michel C; Mignon F; Najman A
    Nephrol Dial Transplant; 1993; 8(7):614-20. PubMed ID: 8396745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
    Vannucchi AM; Bosi A; Lombardini L; Grossi A; Bacci P; Guidi S; Saccardi R; Rossi-Ferrini P
    Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating erythroid progenitors in the anemia of prematurity.
    Shannon KM; Naylor GS; Torkildson JC; Clemons GK; Schaffner V; Goldman SL; Lewis K; Bryant P; Phibbs R
    N Engl J Med; 1987 Sep; 317(12):728-33. PubMed ID: 3627181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
    Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia.
    Kimura H; Finch CA; Adamson JW
    J Cell Physiol; 1986 Feb; 126(2):298-306. PubMed ID: 3944211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth characteristics of circulating hematopoietic progenitors in terminal renal failure.
    Glaser M
    Med Sci Monit; 2006 Mar; 12(3):CR113-7. PubMed ID: 16501421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
    Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.
    Cairo MS; Wagner EL; Fraser J; Cohen G; van de Ven C; Carter SL; Kernan NA; Kurtzberg J
    Transfusion; 2005 Jun; 45(6):856-66. PubMed ID: 15934982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rHuEPO dose inversely correlated with the number of circulating CD34+ cells in maintenance hemodialysis patients.
    Kohagura K; Ohya Y; Miyagi S; Ishida A; Yakabi S; Iseki K; Yamane N; Takishita S
    Nephron Clin Pract; 2008; 108(1):c41-6. PubMed ID: 18087171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early proliferation of umbilical cord blood cells from premature neonates.
    Luzo AC; Duarte AS; Salles TS; Queiroz ML; Lorand-Metze I; Costa FF; Saad ST
    Vox Sang; 2007 Aug; 93(2):145-53. PubMed ID: 17683358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
    Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P
    Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.